Enhanced anticancer activity and endocytic mechanisms by polymeric nanocarriers ofn-butylidenephthalide in leukemia cells

Purpose The purpose of this study was to investigate the antitumor mechanisms ofn-butylidenephthalide (BP) and to further examine the delivery efficacy of polycationic liposome containing PEI and polyethylene glycol complex (LPPC)-encapsulated BP in leukemia cells. Methods MTS, flow cytometric and T...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical & translational oncology 2021-06, Vol.23 (6), p.1142-1151
Hauptverfasser: Huang, X. -F., Chen, P. -T., Lin, Y. -L., Lee, M. -S., Chang, K. -F., Liao, K. -W., Sheu, G. -T., Hsieh, M. -C., Tsai, N. -M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose The purpose of this study was to investigate the antitumor mechanisms ofn-butylidenephthalide (BP) and to further examine the delivery efficacy of polycationic liposome containing PEI and polyethylene glycol complex (LPPC)-encapsulated BP in leukemia cells. Methods MTS, flow cytometric and TUNEL assays were performed to assess cell viability and apoptosis. BP and BP/LPPC complex delivery efficiency was analyzed by full-wavelength fluorescent scanner and fluorescence microscope. The expressions of cell cycle- and apoptosis-related proteins were conducted by Western blotting. Results The results showed that BP inhibited leukemia cell growth by inducing cell cycle arrest and cell apoptosis. LPPC-encapsulated BP rapidly induced endocytic pathway activation, resulting in the internalization of BP into leukemia cells, causing cell apoptosis within 1 h. Conclusions LPPC encapsulation enhanced the cytotoxic activity of BP and did not influence the effects of BP induction that suggested LPPC-encapsulated BP might be developed as anti-leukemia drugs in future.
ISSN:1699-048X
1699-3055
DOI:10.1007/s12094-020-02500-w